Pharmaceuticals
Mylan raises bid for Perrigo Co to $34.10 bn
29 Apr 2015
As a result of the increased offer, Mylan will own approximately 60.7 per cent of the merged company, while the remaining 39.3 per cent will be held by Perrigo
Perrigo Co rejects Mylan's $33-bn sweetened bid
25 Apr 2015
Generic drugmaker Mylan NV yesterday raised its takeover offer for Perrigo Co to $33 billion, in a move widely seen as an attempt to ward off an unsolicited bid from larger rival Teva Pharmaceuticals
Perrigo rejects Mylan’s $29 bn takeover offer
22 Apr 2015
Teva Pharmaceutical offers to buy Mylan NV for $40 bn
22 Apr 2015
A successful Teva-Mylan merger would be the largest in the pharmaceutical industry this year, which has seen acquisitions taking place at a frenzied pace
